• Je něco špatně v tomto záznamu ?

MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions

M. Hlavna, M. Raudenska, K. Hudcova, J. Gumulec, M. Sztalmachova, V. Tanhäuserova, P. Babula, V. Adam, T. Eckschlager, R. Kizek, M. Masarik,

. 2012 ; 41 (6) : 2237-44.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024249

MicroRNAs (miRNAs) are a large class of single-stranded RNA molecules involved in post-transcriptional gene silencing. miRNAs not only regulate various developmental and physiological processes but also are involved in cancer development. Additionally, they can be considered as biomarkers of some pathological processes. The aim of this study was to determine the expression levels of selected miRNA and zinc(II)-related genes (ZIP-1, BAX, MT2A and MT1A) in the non-tumor PNT1A prostate cell line in comparison with the prostate cancer cell lines 22Rv1, PC-3 and LNCaP after zinc(II) treatment. Using bioinformatic approaches we selected miRNAs with putative binding sites in the 3'UTR regions in Metallothionein 1A and 2A as miRNA 23a, 141, 224, 296-3p, 320, 375 and 376. We observed significantly higher expression of miRNA 23a in all tumor lines compared to non-tumor PNT1A (13.6-fold in 22Rv1, 7.3-fold in PC-3, 8.3-fold in LNCaP, p<0.01). We also observed that the 22Rv1 cell line has significantly higher expression of miRNA 224 in comparison to other cell lines. In addition, all tumor cell lines expressed significantly higher levels of miRNA 375 in comparison to non-tumor PNT1A (87.1‑fold in 22Rv1, nearly 2,000-fold in PC-3, 56.3‑fold in LNCaP, p<0.01). Nevertheless, miRNA 375 and 23a expression levels strongly suggest their potential to contribute to the diagnosis of prostate cancer and miRNA 224 eventually may be suitable for classification of primary tumors. The expression of miRNA 224 in 22Rv1 cell line was negatively correlated with increasing zinc(II) concentration only. Our experiments revealed significant negative correlation of miRNA 376 and MT2A in 22Rv1 and a negative correlation between miRNA 224 and MT1A in PC-3 cells which may denote possible direct regulation of MT genes by specific miRNAs in prostate cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024249
003      
CZ-PrNML
005      
20130710124954.0
007      
ta
008      
130703s2012 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ijo.2012.1655 $2 doi
035    __
$a (PubMed)23064315
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Hlavna, Marian $u Department of Pathological Physiology, Masaryk University, CZ-625 00 Brno, Czech Republic.
245    10
$a MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions / $c M. Hlavna, M. Raudenska, K. Hudcova, J. Gumulec, M. Sztalmachova, V. Tanhäuserova, P. Babula, V. Adam, T. Eckschlager, R. Kizek, M. Masarik,
520    9_
$a MicroRNAs (miRNAs) are a large class of single-stranded RNA molecules involved in post-transcriptional gene silencing. miRNAs not only regulate various developmental and physiological processes but also are involved in cancer development. Additionally, they can be considered as biomarkers of some pathological processes. The aim of this study was to determine the expression levels of selected miRNA and zinc(II)-related genes (ZIP-1, BAX, MT2A and MT1A) in the non-tumor PNT1A prostate cell line in comparison with the prostate cancer cell lines 22Rv1, PC-3 and LNCaP after zinc(II) treatment. Using bioinformatic approaches we selected miRNAs with putative binding sites in the 3'UTR regions in Metallothionein 1A and 2A as miRNA 23a, 141, 224, 296-3p, 320, 375 and 376. We observed significantly higher expression of miRNA 23a in all tumor lines compared to non-tumor PNT1A (13.6-fold in 22Rv1, 7.3-fold in PC-3, 8.3-fold in LNCaP, p<0.01). We also observed that the 22Rv1 cell line has significantly higher expression of miRNA 224 in comparison to other cell lines. In addition, all tumor cell lines expressed significantly higher levels of miRNA 375 in comparison to non-tumor PNT1A (87.1‑fold in 22Rv1, nearly 2,000-fold in PC-3, 56.3‑fold in LNCaP, p<0.01). Nevertheless, miRNA 375 and 23a expression levels strongly suggest their potential to contribute to the diagnosis of prostate cancer and miRNA 224 eventually may be suitable for classification of primary tumors. The expression of miRNA 224 in 22Rv1 cell line was negatively correlated with increasing zinc(II) concentration only. Our experiments revealed significant negative correlation of miRNA 376 and MT2A in 22Rv1 and a negative correlation between miRNA 224 and MT1A in PC-3 cells which may denote possible direct regulation of MT genes by specific miRNAs in prostate cancer.
650    _2
$a dospělí $7 D000328
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a regulace genové exprese u nádorů $x účinky léků $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory prostaty $x genetika $x metabolismus $7 D011471
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a genetická transkripce $x účinky léků $7 D014158
650    _2
$a zinek $x metabolismus $7 D015032
650    _2
$a síran zinečnatý $x farmakologie $7 D019287
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Raudenska, Martina $u -
700    1_
$a Hudcova, Kristyna $u -
700    1_
$a Gumulec, Jaromir $u -
700    1_
$a Sztalmachova, Marketa $u -
700    1_
$a Tanhäuserova, Veronika $u -
700    1_
$a Babula, Petr $u -
700    1_
$a Adam, Vojtěch $u - $7 xx0064599
700    1_
$a Eckschlager, Tomas $u -
700    1_
$a Kizek, Rene $u -
700    1_
$a Masarik, Michal $u -
773    0_
$w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 41, č. 6 (2012), s. 2237-44
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23064315 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20130710125418 $b ABA008
999    __
$a ok $b bmc $g 987929 $s 822629
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 41 $c 6 $d 2237-44 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...